As indolent insulinomas tend to express GLP-1Rs, this may be used to the clinician’s advantage, and GLP-1R PET scans have reasonably high sensitivity and specificity (87% and 94%, respectively). This evidence concerns the gene GLP1R and pancreatic insulinoma.